27620334|t|Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes
27620334|a|Mutations of cardiac sarcomere genes have been identified to cause HCM, but the molecular mechanisms that lead to cardiomyocyte hypertrophy and risk for sudden death are uncertain. The aim of this study was to examine HCM disease mechanisms at play during cardiac differentiation of human HCM specific pluripotent stem cells. We generated a human embryonic stem cell (hESC) line carrying a naturally occurring mutation of MYPBC3 (c.2905 +1 G >A) to study HCM pathogenesis during cardiac differentiation. HCM - specific hESC - derived cardiomyocytes (hESC -CMs) displayed hallmark aspects of HCM including sarcomere disarray, hypertrophy and impaired calcium impulse propagation. HCM hESC -CMs presented a transient haploinsufficiency of cMyBP-C during cardiomyocyte differentiation, but by day 30 post - differentiation cMyBP-C levels were similar to control hESC -CMs. Gene transfer of full-length MYBPC3 during differentiation prevented hypertrophy, sarcomere disarray and improved calcium impulse propagation in HCM hESC -CMs. These findings point to the critical role of MYBPC3 during sarcomere assembly in cardiac myocyte differentiation and suggest developmental influences of MYBPC3 truncating mutations on the mature hypertrophic phenotype.
27620334	10	17	cMyBP-C	T116,T123	C1527800
27620334	18	36	protein expression	T045	C1171362
27620334	37	43	during	T079	C0347984
27620334	44	73	cardiomyocyte differentiation	T043	C1817118
27620334	84	89	human	T016	C0086418
27620334	90	117	hypertrophic cardiomyopathy	T047	C0007194
27620334	118	126	cellular	T059	C0178539
27620334	127	137	phenotypes	T032	C0031437
27620334	141	148	disease	T047	C0012634
27620334	149	157	specific	T080	C0205369
27620334	158	171	human ES cell	T025	C1171346
27620334	172	179	derived	T080	C1441547
27620334	180	194	cardiomyocytes	T025	C0225828
27620334	195	204	Mutations	T045	C0596611
27620334	208	215	cardiac	T023	C0018787
27620334	216	225	sarcomere	T026	C0036225
27620334	226	231	genes	T028	C0017337
27620334	242	252	identified	T080	C0205396
27620334	262	265	HCM	T047	C0007194
27620334	275	295	molecular mechanisms	T044	C1148560
27620334	309	334	cardiomyocyte hypertrophy	T033	C4227331
27620334	339	360	risk for sudden death	T033	C4014370
27620334	365	374	uncertain	T033	C0087130
27620334	413	416	HCM	T047	C0007194
27620334	417	435	disease mechanisms	T062	C1515006
27620334	444	450	during	T079	C0347984
27620334	451	474	cardiac differentiation	T043	C2247990
27620334	478	483	human	T016	C0086418
27620334	484	487	HCM	T047	C0007194
27620334	488	496	specific	T080	C0205369
27620334	497	519	pluripotent stem cells	T025	C0872076
27620334	524	533	generated	T080	C2346631
27620334	536	573	human embryonic stem cell (hESC) line	T025	C1113687
27620334	563	567	hESC	T025	C1113687
27620334	605	613	mutation	T045	C0596611
27620334	617	623	MYPBC3	T028	C1417523
27620334	625	639	c.2905 +1 G >A	T045	C0596611
27620334	650	653	HCM	T047	C0007194
27620334	654	666	pathogenesis	T046	C0699748
27620334	667	673	during	T079	C0347984
27620334	674	697	cardiac differentiation	T043	C2247990
27620334	699	702	HCM	T047	C0007194
27620334	705	713	specific	T080	C0205369
27620334	714	718	hESC	T025	C1171346
27620334	721	728	derived	T080	C1441547
27620334	729	743	cardiomyocytes	T025	C0225828
27620334	745	749	hESC	T025	C1171346
27620334	745	754	hESC -CMs	T025	C0225828
27620334	775	782	aspects	T169	C0015127
27620334	786	789	HCM	T047	C0007194
27620334	790	799	including	T169	C0332257
27620334	800	809	sarcomere	T026	C0036225
27620334	810	818	disarray	T190	C0302142
27620334	820	831	hypertrophy	T046	C0020564
27620334	836	844	impaired	T169	C0221099
27620334	845	872	calcium impulse propagation	T043	C0007613
27620334	874	877	HCM	T047	C0007194
27620334	878	882	hESC	T025	C1171346
27620334	878	887	hESC -CMs	T025	C0225828
27620334	910	928	haploinsufficiency	T049	C2936267
27620334	932	939	cMyBP-C	T116,T123	C1527800
27620334	940	946	during	T079	C0347984
27620334	947	976	cardiomyocyte differentiation	T043	C1817118
27620334	985	988	day	T079	C0439228
27620334	992	996	post	T079	C0687676
27620334	999	1014	differentiation	T043	C1817118
27620334	1015	1022	cMyBP-C	T116,T123	C1527800
27620334	1023	1029	levels	T080	C0441889
27620334	1035	1042	similar	T080	C2348205
27620334	1046	1053	control	T080	C0243148
27620334	1054	1058	hESC	T025	C1171346
27620334	1054	1063	hESC -CMs	T025	C0225828
27620334	1065	1078	Gene transfer	T063	C1517499
27620334	1094	1100	MYBPC3	T028	C1417523
27620334	1101	1107	during	T079	C0347984
27620334	1108	1123	differentiation	T043	C1817118
27620334	1124	1133	prevented	T169	C1292733
27620334	1134	1145	hypertrophy	T046	C0020564
27620334	1147	1156	sarcomere	T026	C0036225
27620334	1157	1165	disarray	T190	C0302142
27620334	1170	1178	improved	T033	C0184511
27620334	1179	1206	calcium impulse propagation	T043	C0007613
27620334	1210	1213	HCM	T047	C0007194
27620334	1214	1218	hESC	T025	C1171346
27620334	1214	1223	hESC -CMs	T025	C0225828
27620334	1231	1239	findings	T033	C0243095
27620334	1253	1261	critical	T080	C1511545
27620334	1262	1266	role	T077	C1705810
27620334	1270	1276	MYBPC3	T028	C1417523
27620334	1277	1283	during	T079	C0347984
27620334	1284	1293	sarcomere	T026	C0036225
27620334	1294	1302	assembly	T043	C0598084
27620334	1306	1337	cardiac myocyte differentiation	T043	C1817118
27620334	1342	1349	suggest	T078	C1705535
27620334	1350	1363	developmental	T080	C0458003
27620334	1364	1374	influences	T077	C4054723
27620334	1378	1384	MYBPC3	T028	C1417523
27620334	1396	1405	mutations	T045	C0596611
27620334	1413	1419	mature	T079	C0205286
27620334	1420	1432	hypertrophic	T169	C0333959
27620334	1433	1442	phenotype	T032	C0031437